Literature DB >> 6186739

ELISA assays for IgM and IgG rheumatoid factors.

A Faith, O Pontesilli, A Unger, G S Panayi, P Johns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6186739     DOI： 10.1016/0022-1759(82)90029-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


× No keyword cloud information.
  31 in total

1.  Measurement of complement activation products in patients with chronic rheumatic diseases.

Authors:  G Auda; E R Holme; J E Davidson; A Zoma; J Veitch; K Whaley
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  IgM rheumatoid factor in congenital syphilis: associations with clinical and laboratory findings.

Authors:  M P Meyer; D W Beatty
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

3.  Monocyte-mediated suppression of anti-DNA antibody production in healthy subjects.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Kinoshita; R Yokohari
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

4.  Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.

Authors:  V Asensi; K Kimeno; I Kawamura; M Sakumoto; K Nomoto
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

5.  Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections.

Authors:  M Coffey; J Hassan; C Feighery; M Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  Serum IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) delineates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis.

Authors:  A Aggarwal; S Dabadghao; S Naik; R Misra
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

7.  Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.

Authors:  P Woo; P J Lachmann; R A Harrison; N Amos; C Cooper; F S Rosen
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

8.  Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients.

Authors:  T L Moore; R W Dorner
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Seronegative rheumatoid arthritis, rheumatoid factor cross reactive idiotype expression, and hidden rheumatoid factors.

Authors:  V R Bonagura; J F Wedgwood; N Agostino; L Hatam; L Mendez; I Jaffe; B Pernis
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

10.  Enhanced T helper cell function for the spontaneous production of IgM rheumatoid factor in vitro in rheumatoid arthritis.

Authors:  V Patel; G S Panayi
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.